These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1378 related items for PubMed ID: 18249305

  • 1. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F, Kirdar S, Karul AB, Ceylan E.
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [Abstract] [Full Text] [Related]

  • 2. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A, Schreder M, Wolzt M, Saliba S, Kapiotis S, Eickhoff P, Burghuber OC.
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [Abstract] [Full Text] [Related]

  • 3. [Systemic inflammation during exacerbations of chronic obstructive pulmonary disease].
    Malo O, Sauleda J, Busquets X, Miralles C, Agustí AG, Noguera A.
    Arch Bronconeumol; 2002 Apr; 38(4):172-6. PubMed ID: 11953269
    [Abstract] [Full Text] [Related]

  • 4. The role of serum leptin and tumor necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients.
    Yang YM, Sun TY, Liu XM.
    Chin Med J (Engl); 2006 Apr 20; 119(8):628-33. PubMed ID: 16635406
    [Abstract] [Full Text] [Related]

  • 5. Circulating visfatin in chronic obstructive pulmonary disease.
    Liu X, Ji Y, Chen J, Li S, Luo F.
    Nutrition; 2009 Apr 20; 25(4):373-8. PubMed ID: 19056239
    [Abstract] [Full Text] [Related]

  • 6. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease.
    Kirdar S, Serter M, Ceylan E, Sener AG, Kavak T, Karadağ F.
    Scand J Clin Lab Invest; 2009 Apr 20; 69(2):219-24. PubMed ID: 18946779
    [Abstract] [Full Text] [Related]

  • 7. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
    Piehl-Aulin K, Jones I, Lindvall B, Magnuson A, Abdel-Halim SM.
    Respiration; 2009 Apr 20; 78(2):191-6. PubMed ID: 19270439
    [Abstract] [Full Text] [Related]

  • 8. Determinants of BMI in patients with COPD.
    Karadag F, Karul AB, Cildag O, Altun C, Gurgey O.
    Respirology; 2004 Mar 20; 9(1):70-5. PubMed ID: 14982605
    [Abstract] [Full Text] [Related]

  • 9. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
    Krommidas G, Kostikas K, Papatheodorou G, Koutsokera A, Gourgoulianis KI, Roussos C, Koulouris NG, Loukides S.
    Respir Med; 2010 Jan 20; 104(1):40-6. PubMed ID: 19782551
    [Abstract] [Full Text] [Related]

  • 10. Correlates of erectile dysfunction in moderate-to-severe chronic obstructive pulmonary disease patients.
    Karadag F, Ozcan H, Karul AB, Ceylan E, Cildag O.
    Respirology; 2007 Mar 20; 12(2):248-53. PubMed ID: 17298458
    [Abstract] [Full Text] [Related]

  • 11. Relationship between triiodothyronine and proinflammatory cytokines in chronic heart failure.
    Lubrano V, Pingitore A, Carpi A, Iervasi G.
    Biomed Pharmacother; 2010 Mar 20; 64(3):165-9. PubMed ID: 19926244
    [Abstract] [Full Text] [Related]

  • 12. Highly elevated C-reactive protein levels in obese patients with COPD: a fat chance?
    Breyer MK, Spruit MA, Celis AP, Rutten EP, Janssen PP, Wouters EF, CIRO Network.
    Clin Nutr; 2009 Dec 20; 28(6):642-7. PubMed ID: 19540024
    [Abstract] [Full Text] [Related]

  • 13. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters.
    Calikoglu M, Sahin G, Unlu A, Ozturk C, Tamer L, Ercan B, Kanik A, Atik U.
    Respiration; 2004 Dec 20; 71(1):45-50. PubMed ID: 14872110
    [Abstract] [Full Text] [Related]

  • 14. [The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].
    Komnata K.
    Pneumonol Alergol Pol; 2010 Dec 20; 78(4):271-8. PubMed ID: 20665447
    [Abstract] [Full Text] [Related]

  • 15. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF, Chin CH, Wang CC, Lin MC.
    Respirology; 2009 Sep 20; 14(7):999-1004. PubMed ID: 19740260
    [Abstract] [Full Text] [Related]

  • 16. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
    Morales S A, Dreyse D J, Díaz P O, Saldías P F, Carrasco M, Lisboa B C.
    Rev Med Chil; 2010 Aug 20; 138(8):957-64. PubMed ID: 21140052
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nutritional status in relation to respiratory impairment and systemic inflammation in patients with acute exacerbations of COPD.
    Skyba P, Kluchova Z, Joppa P, Petrasova D, Tkacova R.
    Med Sci Monit; 2009 Oct 20; 15(10):CR528-533. PubMed ID: 19789512
    [Abstract] [Full Text] [Related]

  • 19. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
    Gatta D, Aliprandi G, Pini L, Zanardini A, Fredi M, Tantucci C.
    Eur Rev Med Pharmacol Sci; 2011 Sep 20; 15(9):1068-73. PubMed ID: 22013730
    [Abstract] [Full Text] [Related]

  • 20. Local inflammation occurs before systemic inflammation in patients with COPD.
    He Z, Chen Y, Chen P, Wu G, Cai S.
    Respirology; 2010 Apr 20; 15(3):478-84. PubMed ID: 20210891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.